Showing results (61-70 of 320) with videos related to

Sort By:
Pageof 32
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|December 23, 2011
Mechanisms underlying reductant-induced reactive oxygen species formation by anticancer copper(II) compoundsChristian R Kowol, Petra Heffeter, Walter Miklos, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 18, 2021
The FAM3C locus that encodes interleukin-like EMT inducer (ILEI) is frequently co-amplified in MET-amplified cancers and contributes to invasivenessUlrike Schmidt, Gerwin Heller, Gerald Timelthaler, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 14, 2017
Distinct activity of the bone-targeted gallium compound KP46 against osteosarcoma cells - synergism with autophagy inhibitionBernd Kubista, Thomas Schoefl, Lisa Mayr, et al.
Antioxidants (Basel, Switzerland)|July 27, 2024
Anthocyanin-Rich Berry Extracts Affect SN-38-Induced Response: A Comparison of Non-Tumorigenic HCEC-1CT and HCT116 Colon Carcinoma CellsCornelia Schmutz, Crepelle Plaza, Franziska Steiger, et al.
International Journal of Molecular Sciences|September 14, 2019
Long-Term Vemurafenib Exposure Induced Alterations of Cell Phenotypes in Melanoma: Increased Cell Migration and Its Association with EGFR ExpressionEszter Molnár, Tamás Garay, Marco Donia, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|April 7, 2010
Organometallic indolo[3,2-c]quinolines versus indolo[3,2-d]benzazepines: synthesis, structural and spectroscopic characterization, and biological efficacyLukas K Filak, Gerhard Mühlgassner, Michael A Jakupec, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|June 28, 2011
Influence of ascorbic acid on the activity of the investigational anticancer drug KP1019Caroline Bartel, Alexander E Egger, Michael A Jakupec, et al.
Angewandte Chemie (International Ed. in English)|August 1, 2014
Tumor-targeting of EGFR inhibitors by hypoxia-mediated activationClaudia Karnthaler-Benbakka, Diana Groza, Kushtrim Kryeziu, et al.
Pageof 32